NCT03532230

Brief Summary

The specific aim of this study is to conduct a prospective, multicenter cohort study over four months to compare the cost of standard of allopathic care (control group, N=90) versus standard of care plus osteopathic manipulative treatment (experimental group, N=90) in a cohort of 180 consecutive patients seeking treatment for chronic low back pain at three osteopathic clinics and three allopathic medical clinics (offering only standard care) located in three different regions of the United States.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
146

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2019

Shorter than P25 for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 9, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 22, 2018

Completed
10 months until next milestone

Study Start

First participant enrolled

March 22, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2020

Completed
Last Updated

May 4, 2020

Status Verified

May 1, 2020

Enrollment Period

11 months

First QC Date

May 9, 2018

Last Update Submit

May 1, 2020

Conditions

Keywords

Chronic Low Back PainOsteopathic Manipulative Medicine

Outcome Measures

Primary Outcomes (1)

  • Total Costs

    The cost data will be collected from the electronic medical record of each patient enrolled in the study. Because the costs for comparable treatments vary with respect to different socioeconomic and geographic regions in the United States, the mean total-healthcare costs per patient will be calculated based on codes for 2018 Medicare fee schedules for each clinic listed in the Current Procedural Terminology (CPT) for office visits, medications, OMT, and referrals.

    4 months

Secondary Outcomes (1)

  • Total Morphine-Equivalents

    4 months

Study Arms (2)

Experimental Group

90 new patients seeking treatment for chronic low back pain. This group will receive standard care plus osteopathic manipulative treatment (OMT) for low back pain.

Procedure: Osteopathic Manipulative Treatment (OMT)

Control Group

90 new patients seeking treatment for chronic low back pain. This group will receive only standard care without osteopathic manipulative treatment (OMT) for low back pain.

Interventions

No specific OMT techniques will be required for the present study. However, data on the number of OMT sessions patients receive will be collected.

Experimental Group

Eligibility Criteria

Age18 Years - 84 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This prospective, multicenter, observational study will follow two groups of patients over four months. The first (experimental) group will be 90 new patients seeking treatment for chronic back pain at three osteopathic clinics. The experimental group will receive standard of care plus osteopathic manipulative treatment (OMT) for low back pain. The second (control) group will be 90 new patients who will receive only standard care without OMT for chronic low back pain as delivered at a local pain clinic.

You may qualify if:

  • M54.16 Lumbar radiculopathy
  • G57.01 Lesion of sciatic nerve, right lower limb
  • G57.02 Lesion of sciatic nerve, left lower limb
  • M48.061 Lumbar spinal stenosis, without neurogenic claudication
  • M48.062 Lumbar spinal stenosis, with neurogenic claudication
  • M47.816 Lumbar spondylosis
  • M48.07 Lumbar spinal stenosis, lumbosacral
  • M54.41 Lumbago with sciatica, right side
  • M54.42 Lumbago with sciatica, left side

You may not qualify if:

  • Patients with diabetic neuropathy, congenital lumbar and sacral abnormalities, lumbar fracture, multiple myeloma, metastatic bone disease, history of spinal and/or pain lasting less than three months will be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Michigan State University

East Lansing, Michigan, 48824, United States

Location

Rowan University SOM NeuroMusculoskeletal Institute

Stratford, New Jersey, 08084, United States

Location

The Pain Associates

Voorhees Township, New Jersey, 08043, United States

Location

MeSH Terms

Conditions

RadiculopathySciatic NeuropathySpinal StenosisSpondylosis

Interventions

Manipulation, Osteopathic

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesMononeuropathiesSpinal DiseasesBone DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Musculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Richard Jermyn, DO

    Rowan University School of Osteopathic Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of the NeuroMusculoskeletal Institute (NMI) and Professor and Chair of Rehabilitation Medicine

Study Record Dates

First Submitted

May 9, 2018

First Posted

May 22, 2018

Study Start

March 22, 2019

Primary Completion

February 28, 2020

Study Completion

February 28, 2020

Last Updated

May 4, 2020

Record last verified: 2020-05

Locations